| Christopher P. Austin, M.D.
Senior Advisor to the Director for Translational
Research
National Human Genome Research Institute
National Institutes of Health
Bethesda, Maryland
www.genome.gov
Dr. Austin received his M.D. from Harvard Medical School in 1986
and did his residency in neurology and held a clinical fellowship
at Massachusetts General Hospital, where he eventually became chief
resident. From 1991 to 1996, he was a Research Fellow in Genetics
at Harvard Medical School.
In his current position as Senior Advisor to the Director for Translational
Research with the National Human Genome Research Institute, Dr.
Austin explores dissemination to academic investigators of the high-throughput
technologies used in the private sector for deriving small molecule
probes of biological pathways. His goal is to expand relationships
with pharmaceutical and biotech companies, and focus on translating
the data produced through the Human Genome Project into new therapeutic
strategies.
From 1996 until taking his position with NIH, Dr. Austin worked
at Merck Research Laboratories, most recently as the Director of
Genomic Neuroscience in the Department of Neuroscience. He played
a key role in Merck's pharmacogenomics program and initiated a drug
development team that identified two molecular targets now being
tested for the treatment of schizophrenia. Dr. Austin left Merck
Research Laboratories in November, 2002.
|